The Neonatal European Study of Inhaled Steroids (NEUROSIS): An EU-Funded International Randomised Controlled Trial in Preterm Infants

Abstract

The study focuses on preterm infants born at < 28 weeks of gestational age (GA) and the main objective is to determine whether the early inhalation of budesonide reduces the risk of mortality and BPD.

Keywords

• low-birth-weight
• early corticosteroid treatment
• chronic lung-disease
• bronchopulmonary dysplasia
• cerebral-palsy
• high-risk
• budesonide
• children
• dexamethasone
• inflammation